Stock OGN ORGANON & CO.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-28 pm EDT 		5-day change 1st Jan Change
20.98 USD -0.05% Intraday chart for Organon & Co. -3.98% +45.49%
May. 24 Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation MT
May. 24 Shanghai Henlius Biotech, Inc. and Organon Announces That the European Medicines Agency Has Validated the Marketing Authorization Applications for Hlx14 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ORGANON & CO.
Other Pharmaceuticals
-0.05%-3.98%+45.49%+7.37% - 5.4B
Bullish
Bullish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. OGN Stock
  4. Charts Organon & Co.
  5. Comparison Chart